BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

876 related articles for article (PubMed ID: 28177825)

  • 21. New vectors for simple and streamlined CRISPR-Cas9 genome editing in Saccharomyces cerevisiae.
    Laughery MF; Hunter T; Brown A; Hoopes J; Ostbye T; Shumaker T; Wyrick JJ
    Yeast; 2015 Dec; 32(12):711-20. PubMed ID: 26305040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. "Split-and-Click" sgRNA.
    Taemaitree L; Shivalingam A; El-Sagheer AH; Brown T
    Methods Mol Biol; 2021; 2162():61-78. PubMed ID: 32926378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of Multiple Genome Modifications Induced by the CRISPR/Cas9 System.
    Ota S; Kawahara A
    Methods Mol Biol; 2016; 1451():53-63. PubMed ID: 27464800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Guide RNA engineering for versatile Cas9 functionality.
    Nowak CM; Lawson S; Zerez M; Bleris L
    Nucleic Acids Res; 2016 Nov; 44(20):9555-9564. PubMed ID: 27733506
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CRISPR/Cas9-mediated 2-sgRNA cleavage facilitates pseudorabies virus editing.
    Tang YD; Guo JC; Wang TY; Zhao K; Liu JT; Gao JC; Tian ZJ; An TQ; Cai XH
    FASEB J; 2018 Aug; 32(8):4293-4301. PubMed ID: 29509513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthetic CRISPR RNA-Cas9-guided genome editing in human cells.
    Rahdar M; McMahon MA; Prakash TP; Swayze EE; Bennett CF; Cleveland DW
    Proc Natl Acad Sci U S A; 2015 Dec; 112(51):E7110-7. PubMed ID: 26589814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CRISPR multitargeter: a web tool to find common and unique CRISPR single guide RNA targets in a set of similar sequences.
    Prykhozhij SV; Rajan V; Gaston D; Berman JN
    PLoS One; 2015; 10(3):e0119372. PubMed ID: 25742428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Era of Genomic Medicine: A Narrative Review on CRISPR Technology as a Potential Therapeutic Tool for Human Diseases.
    Kotagama OW; Jayasinghe CD; Abeysinghe T
    Biomed Res Int; 2019; 2019():1369682. PubMed ID: 31687377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generalizable sgRNA design for improved CRISPR/Cas9 editing efficiency.
    Hiranniramol K; Chen Y; Liu W; Wang X
    Bioinformatics; 2020 May; 36(9):2684-2689. PubMed ID: 31971562
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Application of the CRISPR/Cas system for genome editing in microalgae.
    Zhang YT; Jiang JY; Shi TQ; Sun XM; Zhao QY; Huang H; Ren LJ
    Appl Microbiol Biotechnol; 2019 Apr; 103(8):3239-3248. PubMed ID: 30877356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. mCAL: A New Approach for Versatile Multiplex Action of Cas9 Using One sgRNA and Loci Flanked by a Programmed Target Sequence.
    Finnigan GC; Thorner J
    G3 (Bethesda); 2016 Jul; 6(7):2147-56. PubMed ID: 27185399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction of off-target specificity and cell-specific fitness of CRISPR-Cas System using attention boosted deep learning and network-based gene feature.
    Liu Q; He D; Xie L
    PLoS Comput Biol; 2019 Oct; 15(10):e1007480. PubMed ID: 31658261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expanding the Biologist's Toolkit with CRISPR-Cas9.
    Sternberg SH; Doudna JA
    Mol Cell; 2015 May; 58(4):568-74. PubMed ID: 26000842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. All-in-One CRISPR-Cas9/FokI-dCas9 Vector-Mediated Multiplex Genome Engineering in Cultured Cells.
    Sakuma T; Sakamoto T; Yamamoto T
    Methods Mol Biol; 2017; 1498():41-56. PubMed ID: 27709568
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CRISPR-Cas9-Mediated Genome Editing and Transcriptional Control in Yarrowia lipolytica.
    Schwartz C; Wheeldon I
    Methods Mol Biol; 2018; 1772():327-345. PubMed ID: 29754237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SeqCor: correct the effect of guide RNA sequences in clustered regularly interspaced short palindromic repeats/Cas9 screening by machine learning algorithm.
    Liu X; Yang Y; Qiu Y; Reyad-Ul-Ferdous M; Ding Q; Wang Y
    J Genet Genomics; 2020 Nov; 47(11):672-680. PubMed ID: 33451939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of CRISPR/Cas9 site-specific function and validation of sgRNA sequence by a Cas9/sgRNA-assisted reverse PCR technique.
    Zhang B; Zhou J; Li M; Wei Y; Wang J; Wang Y; Shi P; Li X; Huang Z; Tang H; Song Z
    Anal Bioanal Chem; 2021 Apr; 413(9):2447-2456. PubMed ID: 33661348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Minimal 2'-O-methyl phosphorothioate linkage modification pattern of synthetic guide RNAs for increased stability and efficient CRISPR-Cas9 gene editing avoiding cellular toxicity.
    Basila M; Kelley ML; Smith AVB
    PLoS One; 2017; 12(11):e0188593. PubMed ID: 29176845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Engineering Introns to Express RNA Guides for Cas9- and Cpf1-Mediated Multiplex Genome Editing.
    Ding D; Chen K; Chen Y; Li H; Xie K
    Mol Plant; 2018 Apr; 11(4):542-552. PubMed ID: 29462720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Guide RNA functional modules direct Cas9 activity and orthogonality.
    Briner AE; Donohoue PD; Gomaa AA; Selle K; Slorach EM; Nye CH; Haurwitz RE; Beisel CL; May AP; Barrangou R
    Mol Cell; 2014 Oct; 56(2):333-339. PubMed ID: 25373540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.